preregistered

TL3 Research methods · Vienna, AT

I read protocols before results. It changes what you notice.

Joined 27 December 2024 · last posted 15h · groups: journal-club

123 posts, newest first. Showing up to 150.

A structured critique template this community uses — a second dataset Replied, post #52 · Evidence › Study critique · 27 Jul 2026 · 0 likes The practical version of structured critique template is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #95 · Practice › Interactions · 27 Jul 2026 · 5 likes I read post #92 twice before replying, because I had assumed the opposite. Antibiotics: I have looked for the primary source twice and failed twice. Either it does not…
Batch numbers that do not match the vial label Replied, post #48 · Sourcing › Red flags · 24 Jul 2026 · 0 likes Marking my uncertainty on batch numbers explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it generalises…
Aggregate verification data across the directory, with caveats Replied, post #64 · Sourcing › Independent verification · 22 Jul 2026 · 15 likes Thank you — that answers what I came here to find out.
Here for the analytics and not much else Replied, post #72 · Lounge › Introductions · 22 Jul 2026 · 0 likes Welcome: the response to introductions is usually welcome. People will reply to introduce themselves back or to let you know they are glad you are here. That is where I…
Ultrasound and skinfolds: operator dependence in practice Replied, post #66 · Outcomes › Body composition · 19 Jul 2026 · 24 likes This follows post #63 rather than contradicting it. The useful distinction on ultrasound and skinfolds is between what was measured and what was inferred from it. Both…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #77 · Evidence › Journal club · 17 Jul 2026 · 0 likes Offering a way to settle SUSTAIN 6 rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the noise,…
Aggregate verification data across the directory, with caveats Replied, post #51 · Sourcing › Independent verification · 16 Jul 2026 · 0 likes A note on how aggregate verification data gets discussed rather than on aggregate verification data itself: the confident posts get the replies and the careful ones get…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #117 · Evidence › Journal club · 14 Jul 2026 · 0 likes Useful. I have added it to my own notes with the date on it.
Publication patterns in the BPC-157 literature, examined Replied, post #35 · Compounds › Repair & healing peptides · 14 Jul 2026 · 2 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #84 · Analytics › Method validation · 10 Jul 2026 · 23 likes I would call the community position on Specificity likely rather than established, and I would be comfortable defending that hedge.
Alcohol: what is documented and what is folklore Replied, post #101 · Practice › Interactions · 9 Jul 2026 · 0 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #72 · Sourcing › Independent verification · 7 Jul 2026 · 19 likes What a supplier does when asked is itself information, and it is information that a chromatogram cannot provide. That matches what I was told, which is not the same as…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #55 · Analytics › Home & field testing · 22 Jun 2026 · 17 likes If you are new and reading this thread for the answer to Lateral-flow and colorimetric approaches: the answer is conditional, the conditions are in the third reply, and…
Request: a per-category review queue Replied, post #52 · Meta › Feature requests · 22 Jun 2026 · 2 likes Everything in post #48 holds. The case it does not cover is the one I have. Use case: explain why you think the feature would help. "I would use this to..." makes the…
Alcohol: what is documented and what is folklore Replied, post #68 · Practice › Interactions · 20 Jun 2026 · 1 like A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
The anatomy of a question that gets answered within an hour Replied, post #81 · Start Here › How to Ask · 17 Jun 2026 · 24 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. This is the sort of thing that ought…
What would change my mind about repair peptides: a specific answer Replied, post #8 · Compounds › Repair & healing peptides · 9 Jun 2026 · 29 likes Reported local reactions are common enough in first-hand accounts here to be worth mentioning and are not characterised in any published series. I would want to see it…
Second pass at: Metformin co-administration and additive GI effects Replied, post #116 · Practice › Interactions · 31 May 2026 · 0 likes The most useful thing anyone has posted about Metformin co-administration in this category was a table of what had been measured and by whom. That is what I would want…
A parcel stationary at a customs facility for nine days Replied, post #62 · Sourcing › Logistics · 22 May 2026 · 8 likes Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #58 · Evidence › Preprints · 21 May 2026 · 4 likes That is a fair summary of where the discussion has got to.
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #30 · Clinical › Comorbidities · 20 May 2026 · 0 likes An honest declaration on PCOS and metabolic overlap: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than…
Injection volume, overload, and peak distortion Replied, post #12 · Analytics › HPLC & UHPLC · 19 May 2026 · 31 likes Injection volume matters because column overload distorts peak shape, and an overloaded main peak can swallow a small neighbour. A certificate without injection volume…
A 10 mg vial reconstituted three different ways, compared Replied, post #20 · Practice › Reconstitution · 15 May 2026 · 10 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
Alcohol: what is documented and what is folklore Replied, post #3 · Practice › Interactions · 5 May 2026 · 0 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. Alcohol is not contraindicated in the labelling and it does irritate a…
Request: show the solution author in the topic list — what changed since Replied, post #64 · Meta › Feature requests · 3 May 2026 · 5 likes Appreciated. The plain phrasing does more work here than a longer post would.
Reading a home test result without over-claiming Replied, post #30 · Analytics › Home & field testing · 3 May 2026 · 0 likes Building on post #27 rather than restating it. On reading a home test result, I would rather understate and be corrected upward than overstate and be quoted. That is a…
Resolution and tailing factor: real acceptance criteria Replied, post #2 · Analytics › HPLC & UHPLC · 24 Apr 2026 · 12 likes Narrowing the opening post, because the general version has more than one answer. Particle size and column dimensions determine what resolution is achievable at all. A…
Type 2 diabetes and the largest part of the evidence base Replied, post #77 · Clinical › Comorbidities · 21 Apr 2026 · 1 like I had read the opposite somewhere and cannot now find where, which tells me something.
Run-in periods and the population they select Replied, post #102 · Evidence › Trials · 19 Apr 2026 · 7 likes Summarising the run-in periods thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the…
Reconstitution volumes that produce round numbers, tabulated Replied, post #91 · Practice › Reconstitution · 15 Apr 2026 · 2 likes Building on post #88 rather than restating it. I have been on both sides of the reconstitution volumes argument in this category within eighteen months, which should…
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #100 · Analytics › Mass spectrometry · 8 Apr 2026 · 1 like Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory. Not a…
Tracking semaglutide's approved indications across jurisdictions, dated Started this topic · Compounds › Semaglutide · 8 Apr 2026 · 41 likes Tracking semaglutide's approved indications across jurisdictions, dated Writing it up because I had to work it out twice and would rather nobody else did. Putting the…
Pancreatitis history and the risk calculus Started this topic · Safety › Contraindications · 1 Apr 2026 · 0 likes Posting this under the heading it deserves: Pancreatitis history and the risk calculus Everything below is what sits behind that. I would like to know what people here…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #111 · Pharmacology › Pharmacokinetics · 20 Mar 2026 · 2 likes Steady state is approached in roughly four to five half-lives. For a compound with a week-long half-life that is four to five weeks, which is where the escalation…
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #69 · Outcomes › Body composition · 17 Mar 2026 · 1 like Worth separating two things that post #67 runs together. Neither method is capable of detecting the month-to-month changes that people report detecting month to month.…
Type 2 diabetes and the largest part of the evidence base Replied, post #33 · Clinical › Comorbidities · 17 Mar 2026 · 18 likes I had written a reply contradicting post #31 and deleted it. Here is what survived. Asking about a population rather than about yourself is a legitimate framing and…
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #13 · Compounds › Semaglutide · 14 Mar 2026 · 32 likes Narrowing post #12, because the general version has more than one answer. On dose steps: the four-week interval in the pivotal programme was a trial design choice, and…
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #58 · Compounds › Cagrilintide & amylin analogues · 11 Mar 2026 · 5 likes Cagrilintide is a long-acting amylin analogue, which puts it in a different mechanistic family from the incretin agonists it is usually discussed alongside. Amylin…
Micro-titration: a disputed topic, argued properly — one year on Replied, post #11 · Practice › Dosing & titration · 7 Mar 2026 · 3 likes Post #9 put the caveat in the right place and I want to underline it. The number people quote for Micro-titration is a central estimate presented without its interval,…
Reconstitution volumes that produce round numbers, tabulated Replied, post #55 · Practice › Reconstitution · 27 Feb 2026 · 5 likes Building on post #52 rather than restating it. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into…
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #29 · Analytics › Impurities & related substances · 23 Feb 2026 · 3 likes Building on post #26 rather than restating it. Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #64 · Analytics › Impurities & related substances · 18 Feb 2026 · 7 likes Post #62 is right about the mechanism and I think understates the practical bit. That last point is the ceiling on what any purity figure can claim. A method that…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #33 · Clinical › Special populations · 22 Jan 2026 · 14 likes Nothing in this subcategory is medical advice and the questions asked here are precisely the ones that need an individual assessment. The general case is well covered;…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #47 · Sourcing › Red flags · 12 Jan 2026 · 0 likes Answering the question post #45 raises rather than the one it answers. An unexplained discrepancy that the supplier declined to address is a legitimate thing to record,…
Can a home kit substitute for a laboratory report? A careful no Replied, post #89 · Analytics › Home & field testing · 26 Dec 2025 · 27 likes Adding the measurement that post #86 says would settle it. I have been on both sides of the home kit substitute argument in this category within eighteen months, which…
Substitution between formats during a shortage Replied, post #122 · Access › Shortages · 23 Dec 2025 · 28 likes Worth separating substitution between formats as a question about the compound from substitution between formats as a question about the documentation. They get…
Tirzepatide's shorter half-life and its one practical consequence Replied, post #18 · Compounds › Tirzepatide · 1 Dec 2025 · 0 likes I came in to disagree and I am leaving without a disagreement.
Pooling trials with different estimands — what changed since Replied, post #56 · Evidence › Meta-analyses · 25 Nov 2025 · 0 likes Where the included trials share a sponsor and a protocol template, their errors correlate and pooling does not average them out. Adding it because I spent an afternoon…
Second pass at: Programming during a large energy deficit Replied, post #93 · Nutrition & Training › Resistance training · 23 Nov 2025 · 0 likes Coming back to post #92, because the follow-up matters more than the original answer. Recovery capacity falls with energy availability, so a programme that worked at…
Dead volume across syringe and needle combinations Replied, post #27 · Devices › Syringes & needles · 21 Nov 2025 · 7 likes I would be cautious about generalising from the dead volume across syringe example above. It is a good example. It is one example.
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #36 · Sourcing › Vendor reports · 18 Nov 2025 · 10 likes Post #32 and I disagree about the size of the effect, not about the direction. Do not adjust a reported figure. Post what the laboratory said and put your…
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #16 · Analytics › Method validation · 16 Nov 2025 · 2 likes Marking my uncertainty on inter-laboratory comparison explicitly. I am confident about the direction, much less confident about the size, and not confident at all that…
Robustness: the parameters worth deliberately varying Replied, post #3 · Analytics › Method validation · 15 Nov 2025 · 4 likes I have no financial interest in anything named in this thread and I want to say so before I comment on robustness, because it is the sort of subject where it matters.
EMA product information as a primary source Replied, post #60 · Regional › European Union · 12 Nov 2025 · 24 likes Building on post #57 rather than restating it. Trying to state the EMA product information position in a way that someone who disagrees would recognise as fair, because…
[2026 update] What steady state means for the decision to escalate Replied, post #5 · Practice › Dosing & titration · 4 Nov 2025 · 12 likes I had written a reply contradicting post #3 and deleted it. Here is what survived. The starting dose in most of these programmes is a tolerance step and produces little…
Availability by country, dated, with primary sources Replied, post #39 · Access › International · 30 Oct 2025 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
Where to report an adverse event officially, by region — a second dataset Replied, post #51 · Safety › Adverse events · 24 Oct 2025 · 4 likes I read post #47 twice before replying, because I had assumed the opposite. Attribution is genuinely hard for a single case and the reporting schemes are designed to…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #8 · Pharmacology › Pharmacokinetics · 24 Oct 2025 · 16 likes Confirming post #6 from a second method, which matters more than confirming it from a second person. A pharmacokinetic model fitted to trial data describes the…
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #66 · Practice › Dosing & titration · 22 Oct 2025 · 11 likes If you are stepping up mainly because the schedule says so rather than because the current dose has stopped doing what you wanted, that is worth noticing before rather…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #13 · Compounds › Oral incretins · 21 Oct 2025 · 27 likes Narrowing post #10, because the general version has more than one answer. The absorption enhancer in the licensed oral product works by transiently raising local…
[2026 update] Long-time reader, first-time poster Replied, post #19 · Lounge › Introductions · 21 Oct 2025 · 3 likes This is the sort of exchange that makes the archive worth searching.
Payment mechanics and the recovery options that do not exist Replied, post #16 · Sourcing › Payments · 19 Oct 2025 · 21 likes Order confirmations that state the lot to be shipped are rare and are the single most useful thing a supplier can put on one.
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #46 · Compounds › Tirzepatide · 16 Oct 2025 · 1 like Answering the question post #44 raises rather than the one it answers. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is…
What a 2 ppm match establishes, and what it does not Replied, post #58 · Analytics › Mass spectrometry · 9 Oct 2025 · 19 likes Post #57 is right about the mechanism and I think understates the practical bit. My understanding of 2 ppm match is a few years old and may have been superseded. If it…
Availability by country, dated, with primary sources Replied, post #9 · Access › International · 3 Oct 2025 · 12 likes Availability, approval and reimbursement are three separate questions and a country can be in a different state on each. I would put the burden of proof on the…
Temperature loggers worth the money — the long version Replied, post #48 · Devices › Cold chain · 29 Sep 2025 · 6 likes I have been on both sides of the Temperature loggers worth the money argument in this category within eighteen months, which should tell you how strong the evidence for…
Temperature logging at home: what is worth the effort Replied, post #2 · Practice › Storage & stability · 21 Sep 2025 · 24 likes Desiccant in the secondary packaging is a small sign that somebody thought about the dry state. Its absence is not a fault and its presence is worth noticing.
How to read a forest plot, properly, from scratch Replied, post #26 · Evidence › Trials · 11 Sep 2025 · 30 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
Revisiting: German, French and Dutch differences, compared Replied, post #69 · Regional › European Union · 7 Sep 2025 · 28 likes A methods point on German rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #127 · Compounds › Secretagogues & GH axis · 3 Sep 2025 · 7 likes Picking up post #125: that is the part I would want checked first. A mass result for a short peptide is more discriminating than for a long one, because a single…
Second pass at: The mass-error checker and its intended scope Replied, post #8 · Data & Tools › Calculators · 30 Aug 2025 · 0 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #106 · Evidence › Journal club · 24 Aug 2025 · 1 like Post #105 is right about the mechanism and I think understates the practical bit. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight…
Managing an unplanned gap in supply — what changed since Replied, post #32 · Access › Shortages · 6 Aug 2025 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
A comparison of home results against a laboratory result on the same vial Replied, post #21 · Analytics › Home & field testing · 4 Aug 2025 · 0 likes Confirming post #18 from a second method, which matters more than confirming it from a second person. Immunoassay limitations: tests that use antibodies have…
A ten-fold dose error caught before injection — one year on Replied, post #95 · Devices › Syringes & needles · 3 Aug 2025 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #20 · Practice › Administration · 31 Jul 2025 · 18 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #22 · Analytics › COA interpretation · 13 Jul 2025 · 1 like On post #20 — agreed on the reasoning, with one qualification. Where two documents for the same lot disagree, the useful question is which was measured and which was…
Second pass at: Two scans six weeks apart on different machines: a cautionary tale Replied, post #2 · Outcomes › Body composition · 12 Jul 2025 · 10 likes Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat. That distinction might matter but requires different imaging to measure.…
Request: a diff view for wiki revisions — the long version Replied, post #17 · Meta › Feature requests · 9 Jul 2025 · 3 likes Coming back to post #13, because the follow-up matters more than the original answer. Speaking only to diff view for wiki revisions as I have actually seen it, rather…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #66 · Evidence › Journal club · 4 Jul 2025 · 0 likes The arithmetic on CagriSema phase 2 combination paper is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and…
Sequence verification for an obscure compound: how it is done Replied, post #80 · Compounds › Other compounds · 2 Jul 2025 · 8 likes Where I part company with post #78, and it is a narrow parting. Sequence verification: for an obscure compound, a report of the amino acid sequence or a…
Reading a regulatory notice rather than an article about it — what changed since Replied, post #31 · Sourcing › Regulatory · 30 Jun 2025 · 0 likes I would be cautious about generalising from the Reading a regulatory notice example above. It is a good example. It is one example.
Reading a chromatogram someone posted without axes Replied, post #52 · Analytics › HPLC & UHPLC · 30 Jun 2025 · 0 likes An observation about reading a chromatogram that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than…
[2026 update] Clearance pathways and what renal impairment changes Replied, post #70 · Pharmacology › Pharmacokinetics · 28 Jun 2025 · 11 likes Post #66 and I disagree about the size of the effect, not about the direction. Renal impairment changes clearance for some compounds in this class and not others, and…
Reading a supplier's product description as a marketing document Replied, post #32 · Compounds › Other compounds · 11 Jun 2025 · 0 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Hepatic steatosis: what the MASH trial evidence supports Replied, post #54 · Clinical › Comorbidities · 1 Jun 2025 · 0 likes Where a condition is well controlled and where it is not are different questions and the published data rarely distinguishes them.
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #13 · Practice › Dosing & titration · 15 May 2025 · 5 likes Holding at a dose that is working is a legitimate position and it is not what the trial protocols did. The protocols escalated to a target because they were measuring…
Reading a trial's population section before its results — does this still hold? Replied, post #48 · Evidence › Trials · 28 Apr 2025 · 14 likes Reading the supplementary appendix is where most of the real information is, and it is where almost nobody goes. The baseline table alone answers half the…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #20 · Sourcing › Independent verification · 27 Apr 2025 · 0 likes A definition problem is doing most of the work in this Janoshik discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is left is…
Coming back to: Sample size calculations, read backwards from the published number Replied, post #15 · Evidence › Trials · 20 Apr 2025 · 15 likes Where I part company with post #11, and it is a narrow parting. Number needed to treat is only interpretable with the duration attached. The same NNT over one year and…
When "no data" is the complete and final answer Replied, post #149 · Compounds › Other compounds · 15 Apr 2025 · 11 likes The honest summary for most of this subcategory: a plausible mechanism, animal data, and first-hand accounts. Saying so is more useful than assembling the accounts into…
Asking about a compound your prescriber has not heard of Replied, post #12 · Clinical › Prescriber conversations · 7 Apr 2025 · 0 likes If the answer is no, asking for the reason is reasonable and the reason is usually specific. It is also what makes an appeal possible where one exists. That is the…
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #8 · Devices › Pens & autoinjectors · 6 Apr 2025 · 0 likes Dose counters: pens show the remaining number of doses. When the counter reaches zero, the pen is empty and cannot deliver more. Noting the counter before injection…
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #38 · Practice › Interactions · 6 Apr 2025 · 0 likes Oral contraceptive absorption has been studied specifically for some compounds in this class and the findings are compound-specific. Generalising from one to another is…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #6 · Evidence › Trials · 4 Apr 2025 · 14 likes I read the earlier replies on Comparators chosen for regulatory reasons twice before writing this, because I had assumed the opposite and wanted to be sure I was…
A supplier who responds to a discrepancy with silence Replied, post #2 · Sourcing › Red flags · 30 Mar 2025 · 0 likes An unexplained discrepancy that the supplier declined to address is a legitimate thing to record, stated as exactly that and nothing more. That has held every time I…
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #46 · Evidence › Journal club · 16 Mar 2025 · 1 like Answering the question post #42 raises rather than the one it answers. The baseline characteristics table is the single most useful page for the questions that get…
Adjudicated events and why the definition matters — the long version Replied, post #36 · Evidence › Trials · 6 Mar 2025 · 1 like Small correction to my own earlier position on Adjudicated events. I had the units the wrong way round, which changes the conclusion by an order of magnitude and…
Consistent declarations and why they matter more than clever ones Replied, post #132 · Sourcing › Logistics · 5 Mar 2025 · 0 likes Recording ordinary deliveries is what makes the record useful. A file of only the bad ones cannot tell you the rate. If it helps: the failure mode here is usually…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #39 · Practice › Reconstitution · 2 Mar 2025 · 4 likes The arithmetic in post #36 is right; the assumption feeding it is the part to check. Adding what did not work for me on reconstituting a multi-strength kit, since the…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #53 · Compounds › Semaglutide · 6 Feb 2025 · 17 likes I would rather this thread reach "we do not know" about published dose-response for semaglutide than reach a confident answer that nobody can support when asked.
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #22 · Devices › Syringes & needles · 23 Jan 2025 · 14 likes Everything in post #20 holds. The case it does not cover is the one I have. Adding a reference point for Gauge and length selection. Mine is a single case, collected…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #17 · Compounds › Semaglutide · 4 Jan 2025 · 0 likes Post #15 describes the usual case. This is about the unusual one. On formulation: the licensed product is buffered and includes a preservative in the multi-dose…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #103 · Access › Insurance & coverage · 4 Jan 2025 · 0 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
Pancreatitis history and the risk calculus — a second dataset Replied, post #17 · Safety › Contraindications · 21 Dec 2024 · 0 likes If you are new and reading this thread for the answer to Pancreatitis history: the answer is conditional, the conditions are in the third reply, and the rest of the…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #35 · Practice › Reconstitution · 4 Dec 2024 · 15 likes Confirming post #32 from a second method, which matters more than confirming it from a second person. Worked example, since the arithmetic is the whole question. Five…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #113 · Clinical › Prescriber conversations · 2 Dec 2024 · 6 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #150 · Compounds › Repair & healing peptides · 26 Nov 2024 · 4 likes This settles it for me, at least until somebody posts a reason it should not.
Converting between mg/mL and units per dose, both directions Replied, post #100 · Practice › Reconstitution · 23 Nov 2024 · 1 like Post #97 is the version of this I will quote in future. One addition. Preservative effectiveness is tested against a defined microbial challenge under defined…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #122 · Compounds › Other compounds · 17 Nov 2024 · 5 likes The arithmetic in post #119 is right; the assumption feeding it is the part to check. What I can speak to on Melanocortin agonists is narrow, so I will keep it narrow…
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #6 · Sourcing › Independent verification · 22 Oct 2024 · 0 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible.
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #55 · Clinical › Comorbidities · 18 Oct 2024 · 9 likes Everything in post #53 holds. The case it does not cover is the one I have. Reading this Hypertension improvement thread as someone who came in with a fixed view: the…
Progressive overload when the scale is falling — one year on Replied, post #127 · Nutrition & Training › Resistance training · 5 Oct 2024 · 0 likes Counterpoint on Progressive overload, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one…
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #2 · Compounds › Tirzepatide · 24 Sep 2024 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
Second pass at: Albumin binding and how it produces a long half-life Replied, post #4 · Pharmacology › Pharmacokinetics · 23 Sep 2024 · 3 likes Protein binding reduces the free fraction that is pharmacologically active and extends duration. Both effects come from the same property and only one of them is…
Gallbladder disease risk with rapid weight loss Replied, post #4 · Clinical › Comorbidities · 26 Aug 2024 · 4 likes On post #2 — agreed on the reasoning, with one qualification. Nothing here is medical advice and clinicians posting in this subcategory say so on their own account…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #46 · Nutrition & Training › Hydration & electrolytes · 18 Aug 2024 · 12 likes Confirming post #44 from a second method, which matters more than confirming it from a second person. Sodium intake often falls sharply when processed food intake…
Guidelines revision: what changed and why Replied, post #20 · Meta › Announcements · 25 Jul 2024 · 12 likes Reading the changed pages: the diff is smaller than the announcement implies, which is reassuring rather than disappointing. A large change to a documentation page…
Journal club: FLOW and the renal composite, component by component Replied, post #56 · Evidence › Journal club · 14 Jul 2024 · 20 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #126 · Practice › Dosing & titration · 10 Jul 2024 · 3 likes The arithmetic in post #124 is right; the assumption feeding it is the part to check. Going back down a step is not a failure and the trials allowed it. Several…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #39 · Practice › Dosing & titration · 7 Jul 2024 · 6 likes Post #35 and I disagree about the size of the effect, not about the direction. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose…
Oral contraceptives and delayed emptying: what the data shows Replied, post #8 · Practice › Interactions · 6 Jul 2024 · 14 likes Everything in post #6 holds. The case it does not cover is the one I have. The practical advice most consistently given by pharmacists here is to keep the timing of…